Project Grant HT94252310788
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$724K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This federal Project Grant award of $1,485,001.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research conducted by the University of Alabama at Birmingham (UAB) to overcome immune exhaustion and dysfunction in breast cancer. The grant, which runs from March 1, 2025 to February 29, 2028, will fund advanced biomedical research exploring innovative approaches to disease prevention, diagnosis, treatment, and management of...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
The University of Alabama at Birmingham (UAB) was awarded a $2,119,086 Project Grant by the Defense Health Agency (DHA) under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the Hedgehog pathway in chronic pancreatitis. The 4-year grant, which began on September 30, 2023, aims to advance scientific understanding and develop new therapeutic approaches for this health condition affecting military service members and veterans....
The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...
The University of Alabama will receive $749,987 under a three-year Project Grant award from the Defense Health Agency to investigate the role of environmental stressors on veteran neurocognitive aging. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will support research from May 2023 to April 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research. This award will...
The University of Alabama at Birmingham (UAB) received a $1,139,184.00 Project Grant award from the Defense Health Agency for the research project "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA". The award, which began on August 15, 2023 and is scheduled for completion on August 14, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). This grant supports UAB's biomedical research efforts to transform health care for Service...
This $633,376 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Alabama at Birmingham (UAB) on September 1, 2023. The grant supports epigenome editing research to reactivate the FOXP3 gene in breast cancer tumors, with the goal of developing new treatments. The research project is scheduled for completion by August 31, 2026. UAB is a public research university known for its interdisciplinary...